HemOnc Today Current Issue

The following articles appeared in the print edition of HemOnc Today.

Table of Contents

• Success of gene therapy in hemophilia B serves as ‘seminal event’ for researchers, patients
• Aggressive tumor characteristics seen in screen-interval breast cancers
• MK-AML patients responded favorably to allogeneic HSCT in first remission
• HPV-associated head and neck cancers increasing in whites, Hispanics
• Beehive extract may be promising therapy for prostate cancer
• Bypassing agents better controlled bleeding in acquired hemophilia A
• EACH2: First-line immunosuppressive therapy did not affect survival in acquired hemophilia A
• FDA overhaul legislation could reach president by July 4
• Histology may predict survival in NSCLC with brain metastases
• IHC screening for EGFR mutations may help identify patients for TKI therapy
• Long-term outcomes positive after HSCT with cyclophosphamide plus antithymocyte globulin
• No greater cancer risk for patients with metal-on-metal hip implants, study says
• Pathology review underused in node-negative breast cancer
• Physicians with healthy habits likely to urge lifestyle changes to patients
• Preoperative chemoradiotherapy improved local control in advanced rectal cancer
• Proteasome inhibitor may have role in treatment of relapsed or refractory multiple myeloma
• PSA screening may benefit younger, at-risk men
• Reovirus showed activity in head and neck cancers
• Researchers identify early biomarker for pancreatic cancer
• Screening for inherited thrombophilia recommended for relatives of children with VTE
• Study finds cancer patients under-referred for orthopedic oncology surgery
• Benefits of Antiplatelet Therapy in Patients with CKD Countered by Bleeding Risks
• Outpatient models offer tremendous potential for transplantation and beyond William Wood, MD
• Bisphosphonates improved some symptoms in patients with multiple myeloma
• Gemcitabine/paclitaxel combination therapy effective in small cell lung cancer, but schedule appeared toxic
• Hispanics with NSCLC appear to live longer than whites and blacks
• Swallowing exercises improved short term capabilities in head and neck cancer
• ALK inhibitor induced strong response in three types of pediatric cancers
• Annual pancreatic cancer screening was sufficient for high, moderate risk patients
• Combination chemotherapy more than doubles PFS in lymphoma patients compared with R-CHOP
• HIV-positive patients exhibited higher prevalence, multiplicity of colorectal polyps
• Intermittent androgen deprivation was less effective for hormone-sensitive metastatic prostate cancer
• Investigational agent significantly improved PFS in patients with HER-2–positive advanced breast cancer
• Multiple obstacles to palliative care identified through focus group study
• RFA reported effective for Barrett’s esophagus patients with a prior fundoplication
• Tumor heterogeneity in luminal-type breast cancer driven by specific mutations
• Performance scales can help physicians, families of pediatric cancer patients make informed decisions Christine A. Zawistowski, MD